These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 35609059)

  • 1. Association of C-peptide and lipoprotein(a) as two predictors with cardiometabolic biomarkers in patients with type 2 diabetes in KERCADR population-based study.
    Mahmoodi MR; Najafipour H
    PLoS One; 2022; 17(5):e0268927. PubMed ID: 35609059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations between serum vitamin D
    Mahmoodi MR; Najafipour H
    BMC Endocr Disord; 2022 May; 22(1):126. PubMed ID: 35549686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents.
    Chin J; Mori TA; Adams LA; Beilin LJ; Huang RC; Olynyk JK; Ayonrinde OT
    JHEP Rep; 2020 Dec; 2(6):100150. PubMed ID: 32984791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol and glucose profiles according to different fasting C-peptide levels: a cross-sectional analysis in a healthy cohort from the Czech Republic.
    Kron V; Verner M; Pesl L; Smetana P; Kadlec J; Martinik D
    J Appl Biomed; 2021 Dec; 19(4):220-227. PubMed ID: 34907741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipoprotein(a) in predicting the severity of new on-set coronary artery disease in type 2 diabetics: A Gensini score evaluation.
    Chen J; Zhang Y; Liu J; Chen MH; Guo YL; Zhu CG; Xu RX; Dong Q; Li JJ
    Diab Vasc Dis Res; 2015 Jul; 12(4):258-64. PubMed ID: 25861813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events.
    Tsimikas S; Mallat Z; Talmud PJ; Kastelein JJ; Wareham NJ; Sandhu MS; Miller ER; Benessiano J; Tedgui A; Witztum JL; Khaw KT; Boekholdt SM
    J Am Coll Cardiol; 2010 Sep; 56(12):946-55. PubMed ID: 20828647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Atherogenic Index of Plasma: A Powerful and Reliable Predictor for Coronary Artery Disease in Patients With Type 2 Diabetes.
    Zhou K; Qin Z; Tian J; Cui K; Yan Y; Lyu S
    Angiology; 2021 Nov; 72(10):934-941. PubMed ID: 33949211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
    Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
    Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients.
    Song P; Xu L; Xu J; Zhang HQ; Yu CX; Guan QB; Zhao M; Zhang X
    Curr Vasc Pharmacol; 2018; 16(6):589-595. PubMed ID: 29299987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Lipoprotein(a) as a potential residual risk factor associated with lipid-rich coronary atheroma in patients with type 2 diabetes and coronary artery disease on statin treatment: Insights from the REASSURE-NIRS registry.
    Nakamura H; Kataoka Y; Nicholls SJ; Puri R; Kitahara S; Murai K; Sawada K; Matama H; Iwai T; Honda S; Fujino M; Takagi K; Yoneda S; Otsuka F; Nishihira K; Asaumi Y; Tsujita K; Noguchi T
    Atherosclerosis; 2022 May; 349():183-189. PubMed ID: 35450750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Profile Modulates Cardiometabolic Risk Biomarkers Including Hypertension in People with Type-2 Diabetes: A Focus on Unbalanced Ratio of Plasma Polyunsaturated/Saturated Fatty Acids.
    Gouaref I; Bouazza A; Abderrhmane SA; Koceir EA
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32962299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIGLYCERIDE/HIGH-DENSITY LIPOPROTEIN CHOLESTEROL CONCENTRATION RATIO IDENTIFIES ACCENTUATED CARDIOMETABOLIC RISK.
    Armato J; Reaven G; Ruby R
    Endocr Pract; 2015 May; 21(5):495-500. PubMed ID: 25667373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated lipoprotein(a) and low-density lipoprotein cholesterol as predictors of the severity and complexity of angiographic lesions in patients with premature coronary artery disease.
    Chieng D; Pang J; Ellis KL; Hillis GS; Watts GF; Schultz CJ
    J Clin Lipidol; 2018; 12(4):1019-1026. PubMed ID: 29703625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C-X-C motif chemokine ligand 14 levels are associated with serum C-peptide and fatty liver index in type 2 diabetes mellitus patients.
    Matsushita Y; Hasegawa Y; Takebe N; Onodera K; Shozushima M; Oda T; Nagasawa K; Honma H; Nata K; Sasaki A; Ishigaki Y
    J Diabetes Investig; 2021 Jun; 12(6):1042-1049. PubMed ID: 33063457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study.
    Lim TS; Yun JS; Cha SA; Song KH; Yoo KD; Ahn YB; Park YM; Ko SH
    Korean J Intern Med; 2016 Nov; 31(6):1110-1119. PubMed ID: 27756118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mixed benefit of low lipoprotein(a) in type 2 diabetes.
    Hermans MP; Ahn SA; Rousseau MF
    Lipids Health Dis; 2017 Sep; 16(1):171. PubMed ID: 28899393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
    Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
    Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of serum lipoprotein (a) levels with type-2 diabetes mellitus in patients with angiographically defined coronary artery disease.
    Pedreño J; Fernández R; Ballester A; Jornet A; Usón M; Canela J; Petit M
    Int J Cardiol; 2000 Jul; 74(2-3):159-67. PubMed ID: 10962116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma apolipoprotein C-III levels, triglycerides, and coronary artery calcification in type 2 diabetics.
    Qamar A; Khetarpal SA; Khera AV; Qasim A; Rader DJ; Reilly MP
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1880-8. PubMed ID: 26069232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.